magazine 24 Nov 2022
Download PDF Page flip version
Discover where managers of investment trusts are finding value in the market and how you can too.
Also in the digital magazine: the latest on Disney, Zoom, UK banks, Grindr’s market debut and the key takeaways from the Autumn Statement.
This week’s investment ideas include a dividend ETF and a pharmaceutical stock with growth potential. We look at one investor’s stock-picking journey which began with buying shares in EasyJet in the wake of the financial crisis.
Plus, mixed fortunes for US consumer-facing names, why a rally for Chinese assets has run out of steam and how Royal Mail can only dream of the efficiency gains achieved by Procter & Gamble.
Virgin Money results suggest plain sailing but big investors are cautious
Top tips for investing against a gloomier economic backdrop
Investors appear to be betting on recovery
Video conferencing platform hit by competition and a return to in-person meetings
The industry has been crying out for consistency from politicians for years
Investors are starting to fear the Chinese government will no longer relax its Covid rules
Frenzied trading in dating app is reminiscent of the meme stock volatility seen during lockdown
Sentiment has soured towards the global food business
American retailers are showing resilience, but the worsening backdrop suggests Christmas could be bleak for some
Robert explains his post-global financial crisis journey that started with a £300 stake in EasyJet
Three things the Franklin Templeton Emerging Markets Equity team are thinking about today
Stocks in the fourth most populous nation on earth are outshining those in other emerging economies
We’re nowhere near bullish territory but professional investors appear less gloomy
The most effective value indicators are often the simplest, but remember they are just a starting point
New tax rules will also affect some listed companies
The postal group has struggled to cut costs whereas the US firm has done so with ease
Stocks in this fund are cheaper than the FTSE 100 and it yields nearly twice as much
Sales of pharma firm’s flagship drug are expected to ramp up significantly
Former CEO’s return to the hot seat is a positive catalyst for for the ‘House of Mouse’
Our expert helps explain how a move overseas could impact retirement income
Important information:
These articles are provided by Shares magazine which is published by AJ Bell Media, a part of AJ Bell. Shares is not written by AJ Bell.
Shares is provided for your general information and use and is not a personal recommendation to invest. It is not intended to be relied upon by you in making or not making any investment decisions. The investments referred to in these articles will not be suitable for all investors. If in doubt please seek appropriate independent financial advice.
Investors acting on the information in these articles do so at their own risk and AJ Bell Media and its staff do not accept liability for losses suffered by investors as a result of their investment decisions.
